Acute adenovirus hepatitis in liver transplant recipients

Brigitte Cames, Jacques Rahier, Guy Burtomboy, Jean de Ville de Goyet, Raymond Reding, Monique Lamy, Jean Bernard Otte, Etienne M. Sokal

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

An acute or fulminant adenovirus hepatitis developed in 5 of 224 pediatric patients who were recipients of orthotopic liver transplants. All had received prednisolone, azathioprine, and cyclosporine as basal immunosuppression, and four received monoclonal (OKT3) or polyclonal (antithymocyte globulin) antibodies for steroid-resistant rejection episodes. These patients initially had high fever and a worsening condition for a mean of 73 days after transplantation (range 44 to 140 days). Results of biochemical tests showed very high serum levels of lactate dehydrogenase. Aspartate aminotransferase values were always markedly more elevated than those of alanine aminotransferase. Two patients had severe leukopenia. Results of histologic studies of the liver showed extensive areas of confluent necrosis and targetlike hepatocyte nuclei. Typical intranuclear viral inclusions were observed on electron microscopy. Adenovirus was cultured in all patients and in two relatives. Two patients died of liver failure; others recovered after cessation of immunosuppression. We conclude that adenovirus hepatitis can be fatal in liver transplant recipients. There is no specific treatment, and immunosuppression must be discontinued.

Original languageEnglish
Pages (from-to)33-37
Number of pages5
JournalJournal of Pediatrics
Volume120
Issue number1
DOIs
Publication statusPublished - 1992

Fingerprint

Adenoviridae
Hepatitis
Liver
Immunosuppression
Muromonab-CD3
Intranuclear Inclusion Bodies
Antilymphocyte Serum
Liver Failure
Azathioprine
Leukopenia
Aspartate Aminotransferases
Prednisolone
Alanine Transaminase
L-Lactate Dehydrogenase
Cyclosporine
Hepatocytes
Electron Microscopy
Fever
Necrosis
Transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Cames, B., Rahier, J., Burtomboy, G., Goyet, J. D. V. D., Reding, R., Lamy, M., ... Sokal, E. M. (1992). Acute adenovirus hepatitis in liver transplant recipients. Journal of Pediatrics, 120(1), 33-37. https://doi.org/10.1016/S0022-3476(05)80593-1

Acute adenovirus hepatitis in liver transplant recipients. / Cames, Brigitte; Rahier, Jacques; Burtomboy, Guy; Goyet, Jean de Ville de; Reding, Raymond; Lamy, Monique; Otte, Jean Bernard; Sokal, Etienne M.

In: Journal of Pediatrics, Vol. 120, No. 1, 1992, p. 33-37.

Research output: Contribution to journalArticle

Cames, B, Rahier, J, Burtomboy, G, Goyet, JDVD, Reding, R, Lamy, M, Otte, JB & Sokal, EM 1992, 'Acute adenovirus hepatitis in liver transplant recipients', Journal of Pediatrics, vol. 120, no. 1, pp. 33-37. https://doi.org/10.1016/S0022-3476(05)80593-1
Cames B, Rahier J, Burtomboy G, Goyet JDVD, Reding R, Lamy M et al. Acute adenovirus hepatitis in liver transplant recipients. Journal of Pediatrics. 1992;120(1):33-37. https://doi.org/10.1016/S0022-3476(05)80593-1
Cames, Brigitte ; Rahier, Jacques ; Burtomboy, Guy ; Goyet, Jean de Ville de ; Reding, Raymond ; Lamy, Monique ; Otte, Jean Bernard ; Sokal, Etienne M. / Acute adenovirus hepatitis in liver transplant recipients. In: Journal of Pediatrics. 1992 ; Vol. 120, No. 1. pp. 33-37.
@article{a553d03f405349f4a72355d0f6c75231,
title = "Acute adenovirus hepatitis in liver transplant recipients",
abstract = "An acute or fulminant adenovirus hepatitis developed in 5 of 224 pediatric patients who were recipients of orthotopic liver transplants. All had received prednisolone, azathioprine, and cyclosporine as basal immunosuppression, and four received monoclonal (OKT3) or polyclonal (antithymocyte globulin) antibodies for steroid-resistant rejection episodes. These patients initially had high fever and a worsening condition for a mean of 73 days after transplantation (range 44 to 140 days). Results of biochemical tests showed very high serum levels of lactate dehydrogenase. Aspartate aminotransferase values were always markedly more elevated than those of alanine aminotransferase. Two patients had severe leukopenia. Results of histologic studies of the liver showed extensive areas of confluent necrosis and targetlike hepatocyte nuclei. Typical intranuclear viral inclusions were observed on electron microscopy. Adenovirus was cultured in all patients and in two relatives. Two patients died of liver failure; others recovered after cessation of immunosuppression. We conclude that adenovirus hepatitis can be fatal in liver transplant recipients. There is no specific treatment, and immunosuppression must be discontinued.",
author = "Brigitte Cames and Jacques Rahier and Guy Burtomboy and Goyet, {Jean de Ville de} and Raymond Reding and Monique Lamy and Otte, {Jean Bernard} and Sokal, {Etienne M.}",
year = "1992",
doi = "10.1016/S0022-3476(05)80593-1",
language = "English",
volume = "120",
pages = "33--37",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Acute adenovirus hepatitis in liver transplant recipients

AU - Cames, Brigitte

AU - Rahier, Jacques

AU - Burtomboy, Guy

AU - Goyet, Jean de Ville de

AU - Reding, Raymond

AU - Lamy, Monique

AU - Otte, Jean Bernard

AU - Sokal, Etienne M.

PY - 1992

Y1 - 1992

N2 - An acute or fulminant adenovirus hepatitis developed in 5 of 224 pediatric patients who were recipients of orthotopic liver transplants. All had received prednisolone, azathioprine, and cyclosporine as basal immunosuppression, and four received monoclonal (OKT3) or polyclonal (antithymocyte globulin) antibodies for steroid-resistant rejection episodes. These patients initially had high fever and a worsening condition for a mean of 73 days after transplantation (range 44 to 140 days). Results of biochemical tests showed very high serum levels of lactate dehydrogenase. Aspartate aminotransferase values were always markedly more elevated than those of alanine aminotransferase. Two patients had severe leukopenia. Results of histologic studies of the liver showed extensive areas of confluent necrosis and targetlike hepatocyte nuclei. Typical intranuclear viral inclusions were observed on electron microscopy. Adenovirus was cultured in all patients and in two relatives. Two patients died of liver failure; others recovered after cessation of immunosuppression. We conclude that adenovirus hepatitis can be fatal in liver transplant recipients. There is no specific treatment, and immunosuppression must be discontinued.

AB - An acute or fulminant adenovirus hepatitis developed in 5 of 224 pediatric patients who were recipients of orthotopic liver transplants. All had received prednisolone, azathioprine, and cyclosporine as basal immunosuppression, and four received monoclonal (OKT3) or polyclonal (antithymocyte globulin) antibodies for steroid-resistant rejection episodes. These patients initially had high fever and a worsening condition for a mean of 73 days after transplantation (range 44 to 140 days). Results of biochemical tests showed very high serum levels of lactate dehydrogenase. Aspartate aminotransferase values were always markedly more elevated than those of alanine aminotransferase. Two patients had severe leukopenia. Results of histologic studies of the liver showed extensive areas of confluent necrosis and targetlike hepatocyte nuclei. Typical intranuclear viral inclusions were observed on electron microscopy. Adenovirus was cultured in all patients and in two relatives. Two patients died of liver failure; others recovered after cessation of immunosuppression. We conclude that adenovirus hepatitis can be fatal in liver transplant recipients. There is no specific treatment, and immunosuppression must be discontinued.

UR - http://www.scopus.com/inward/record.url?scp=0026570004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026570004&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(05)80593-1

DO - 10.1016/S0022-3476(05)80593-1

M3 - Article

C2 - 1731021

AN - SCOPUS:0026570004

VL - 120

SP - 33

EP - 37

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -